SCHEMBL1507659

SCHEMBL1507659

CCCSc1ccc2c(=O)nc[nH]c2c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.40
LMNA P02545 1/20 0.40
TP53 P04637 1/20 0.40
CYP1A2 P05177 1/20 0.40
HPGD P15428 1/20 0.40
MAPK1 P28482 1/20 0.40
KMT2A Q03164 1/20 0.40
KCNH2 Q12809 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
POLB P06746 1/20 0.36
CA12 O43570 1/20 0.36
CA1 P00915 1/20 0.36
CA2 P00918 1/20 0.36
CA7 P43166 1/20 0.36
CA13 Q8N1Q1 1/20 0.36
MAOA P21397 2/20 0.35
MAOB P27338 2/20 0.35
AR P10275 2/20 0.34
BACE1 P56817 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1507606 0.86 POLB (0.37) MEN1LMNATP53CYP1A2HPGD
SCHEMBL30472190 0.79 QPCT (0.46) MEN1LMNATP53CYP1A2HPGD
SCHEMBL29403639 0.79 QPCT (0.46) MEN1LMNATP53CYP1A2HPGD
SCHEMBL1507660 0.77 PARP1 (0.55) CYP1A2SMN1; SMN2CA12CHEK1PARP1
SCHEMBL1507706 0.77 TYMS (0.41) MEN1CYP1A2HPGDKMT2ASMN1; SMN2
SCHEMBL13003705 0.72 PARP1 (0.54) MEN1LMNAKMT2ASMN1; SMN2CHEK1
SCHEMBL29638516 0.72 PARP1 (0.54) MEN1LMNAKMT2ASMN1; SMN2CHEK1
SCHEMBL12489082 0.70 PIM1 (0.51) MEN1HPGDKMT2ASMN1; SMN2POLB
SCHEMBL6772885 0.69 SMN1; SMN2 (0.45) MEN1LMNATP53CYP1A2HPGD
SCHEMBL7291370 0.69 POLB (0.48) HPGDSMN1; SMN2POLBXDHHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3103799-A1 QUINAZOLINE DERIVATIVES OSI Pharmaceuticals, LLC (US) 2016-12-14 EP disclosed
EP-2163546-B1 Quinazoline derivatives PFIZER PROD INC (US) 2016-06-01 EP disclosed
EP-2295415-A1 Quinazoline derivatives OSI Pharmaceuticals, Inc. (US) 2011-03-16 EP disclosed
EP-2163546-A1 Quinazoline derivatives Pfizer Products Incorporated (US) 2010-03-17 EP disclosed
US-RE41065-E1 Alkynl and azido-substituted 4-anilinoquinazolines PFIZER, INC. (US) 2009-12-29 US disclosed
EP-0817775-B1 QUINAZOLINE DERIVATIVES PFIZER (US) 2001-09-12 EP disclosed
EP-1110953-A1 Quinazoline derivatives PFIZER INC. (US) 2001-06-27 EP disclosed
US-5747498-A Alkynyl and azido-substituted 4-anilinoquinazolines PFIZER INC. (US) 1998-05-05 US disclosed
EP-0817775-A1 QUINAZOLINE DERIVATIVES PFIZER INC. (US) 1998-01-14 EP disclosed
WO-1996030347-A1 QUINAZOLINE DERIVATIVES PFIZER INC. (US) 1996-10-03 WO disclosed